← Back to Search

Electrical Stimulation

Active Group A for Urge Incontinence

N/A
Recruiting
Research Sponsored by Elidah, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this research is to evaluate the effectiveness of the ELITONE-UUI electrical muscle stimulation device on treating urge incontinence. The aim of the device is to stimulate the pelvic floor muscles and surrounding structures to improve urinary incontinence.

Eligible Conditions
  • Urge Incontinence

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Efficacy assessed by reduction in average bathroom visits
Efficacy assessed by reduction in average urge incontinence episodes

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Active Group AExperimental Treatment1 Intervention
Electrical muscle stimulator and surface applied electrode shaped to fit the perineal region, with stimulation group A.
Group II: Active Group BActive Control1 Intervention
Electrical muscle stimulator and surface applied electrode shaped to fit the perineal region with stimulation group B.

Find a Location

Who is running the clinical trial?

Elidah, Inc.Lead Sponsor
2 Previous Clinical Trials
42 Total Patients Enrolled
Gloria Kolb, M.S.Study DirectorElidah, Inc.
~8 spots leftby Nov 2025